Understanding HIV Drug Resistance

Data from a World Health Organization report highlights a concerning increase in drug resistance levels to HIV antiretrovirals. What does this mean for HIV care?
The Center for Global Health Policy & Politics, the Fight AIDS Coalition, and the HIV Policy Lab hosted this a virtual discussion on the growing threat of HIV drug resistance and effective ways to address it and reduce associated morbidity and mortality among people living with HIV/AIDS (PLWHA).
Panelists:
Michael R Jordan, MD, MPH, FIDSA, Associate Professor of Medicine, Tufts University
Patricia Asero Ochieng, Team Leader, Dandora Community AIDS Support Association (DACASA)
Sanjana Mukherjee, PhD, MSc, Fellow, Center for Global Health Policy & Politics, O’Neill Institute for National and Global Health Law
Moderator: Sharonann Lynch, Co-Director, Center for Global Health Policy & Politics, O’Neill Institute for National and Global Health Law

[@jonathanmacdonald6725]

😊😊

[@jonathanmacdonald6725]

✋🙋‍♂️

[@jonathanmacdonald6725]

Do we see a potential 6-12 month injetion

[@Alexan-jc4jo]

I have finally been cured thanks Dr Abiola you are indeed a Blessing to this generation #DRABIOLA

[@Alexan-jc4jo]

I have finally been cured thanks Dr Abiola you are indeed a Blessing to this generation #DRABIOLA